Table 2 Details of Patients with Postoperative DVT
sn | Age (year) | BMI (kg/m2) | UD | Diagnosis | Operation | Operation time (min) | Perioperative blood transfusion (unit) | Duration of US (hours) | Location of DVT | Treatment | Note |
|---|---|---|---|---|---|---|---|---|---|---|---|
26 | 68 | 25.5 | HT,DLP | CA colon with ovarian metastasis | Interval debulking TAH and BSO and debulking surgery | 150 | none | 72 | Left gastrocnemius vessle | Enoxapalin 0.4 ➔ 0.6 ml SC OD | LOS 14 days ➔ lost to follow up |
44 | 67 | 21.8 | HT | Uterine cancer (stage IV carcinosarcoma) | TAH and BSO and debulking surgery | 198 | 2 | 120 | Left soleal vein | Enoxapalin 0.5 ml SC q 12 h 3 mos | LOS 12 days ➔ supportive treatment |
51 | 45 | 23.2 | none | endometrioma | TAH and BSO and lysis of adhesions | 224 | none | 47 | Distal right soleal vein | Enoxaparin 0.6 ml sc q 12 h 17 days | LOS 7 days, off enoxaparin due to bleeding per vaginal stump and FU at 5 weeks after that the DVT was disappeared. |
56 | 42 | 25.0 | HT | CA cervix IIIC1(p) Neuroendocrine tumor | RHPL and BSO | 195 | none | 167 | Right soleal vein | None Patient refused treatment | LOS 9 days |
67 | 64 | 24.8 | none | CA ovary (Recurrent) | Debulking tumor with bowel resection and repair vaginal stump and repair bladder | 411 | 2 | 306 | Both soleal vein | Enoxaparin 0.6 ml sc q 12 h for 5 weeks ➔ bemiparin 7500 u sc for 6 months | LOS 19 days |
111 | 83 | 16.2 | HT, CAD | CA fallopian tube stage IIIA2 | TAH with BSO with ascites collection with omentectomy with rectal Bx | 80 | none | 73 | Right soleal vein | enoxaparin 0.4 ml sc od until now | LOS 23 days |